The European Medicines Agency has approved BioNTech-Pfizer as a vaccine against COVID-19



[ad_1]

In recent weeks, the distribution of this vaccine has been authorized in the United Kingdom and the United States.

The EEA’s decision was announced after a closed-door committee meeting during which researchers responsible for evaluating the new vaccine presented the results of their analysis to other experts and examined data provided by the companies.

The final decision must now be made by the European Commission. There is no doubt that it will be positive. In this case, it will be the first vaccine registered in the EU. EC President Ursula von der Leyen said this could be done on Monday night.

Vaccination of people in EU countries is scheduled to start on December 27.

The EU has obtained up to 300 million euros. Biontech and Pfizer vaccine doses. This year, both partners aim to produce up to 50 million. doses, up to 1.3 billion next year.

Studies have shown that the efficacy of this vaccine is 95%.

“I am pleased to announce that the Scientific Committee of the EEA has met today and recommended the conditional release of the vaccine developed by Pfizer and BioNTech in the EU market,” said Emer Cooke, director of the EEA, during a conference of virtual press.

Mr von der Leyen’s Twitter message states that EVA approval is “a crucial moment in our efforts to provide safe and effective vaccines for Europeans.”

“It just came to our notice then. I hope @EU_Commission [Europos Komisijos] decision tonight, ”he added. It was previously predicted that this step would take another 2-3 days.

Officials from Germany and several other European countries have expressed their hope that vaccination in the Community will begin on December 27.

„Moms, [dirbantiems] “BioNTech is a very personal and emotional day,” said Ugur Sahin, CEO and co-founder of the Germany-based company.

“Being in the heart of the EU, we are excited to be one step closer to the possible distribution of the first vaccine in Europe to help combat this devastating pandemic,” he added.

“We are ready to start administering the first doses of the vaccine across the EU as soon as we have the green light,” Sahin said.



[ad_2]